Skip to main content
OpenTrials
Completed

NCT Number: NCT00927537

Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®

The efficacy and tolerability of an antihypertensive treatment with Telmisartan is followed over 3-4 months

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Many Locations, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hypertensive patients seen by the physician requiring antihypertensive treatment

Exclusion criteria

  • According to the local drug information

Treatment and study plan

Telmisartan (Kinzal/Pritor, BAY68-9291)

Drug

Patients under daily life treatment receiving Kinzal according to local drug information.

Telmisartan (Kinzal/Pritor, BAY68-9291) + Hydrochlorothiazide

Drug

Patients under daily life treatment receiving Kinzalplus according to local drug information.

Primary outcomes

  1. Blood pressure

    Time frame: After 1-2 weeks, 1month, 3-4 months

Secondary outcomes

  1. Change in Mean heart rate (bpm)

    Time frame: Baseline and 3-4 month

  2. Change in Mean Weight (kg)

    Time frame: Baseline and 3-4 month

  3. Change in Mean laboratory parameters (total cholesterol, LDL, HDL, triglyceride, fasting blood glucose)

    Time frame: Baseline and 3-4 month

  4. Patient Medical History: Duration of hypertension, Pre-treatment of hypertension, Comorbidities and Concomitant treatment

    Time frame: Baseline

  5. Final evaluation of efficacy (very good, good, sufficient, insufficient) and tolerability (very good, good, sufficient, insufficient) of treatment by the physician.

    Time frame: After 3-4 month

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

Data Collection on Hypertension and Its Treatment With Kinzal®/ Kinzalplus®

Important dates

Study start
2008
Primary completion
2011
Study completion
2011
First posted
Jun 25, 2009
Registry last updated
Sep 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.